BNGO stock

Bionano Genomics Inc (BNGO) financials · rev $28.5M

Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT

Bionano Genomics Inc (BNGO) rev $28.5M.

Cached annual income statement
LineFY2025FY2024
Revenue$28.5M$30.8M
Cost of Revenue$15.3M$30.4M
Gross Profit$13.2M$380.0K
Operating Income-$33.3M-$104.0M
Net Income-$26.4M-$112.0M
EPS (Diluted)-$4.85-$88.13
Cached annual balance sheet
LineFY2025FY2024
Total Assets$73.6M$76.7M
Current Assets$45.4M$39.5M
Cash & Equivalents$2.99M$9.17M
Inventory$7.83M$13.3M
PP&E$14.8M$19.2M
Total Liabilities$29.2M$41.3M
Current Liabilities$22.9M$37.3M
Shareholders' Equity$44.4M$35.4M
Retained Earnings-$719.6M-$693.2M
Cached annual cash flow
LineFY2025FY2024
Operating Cash Flow-$16.3M-$68.9M
Investing Cash Flow-$12.7M$73.8M
Financing Cash Flow$24.0M-$13.7M
Net Change in Cash-$5.06MN/A
These statements as JSON? API free 100/day

FAQ

What is BNGO P/E and revenue?

Bionano Genomics Inc (BNGO) rev $28.5M.

What is BNGO revenue?

Bionano Genomics Inc last cached revenue is $28.5M (FY2025).

Is BNGO profitable?

Bionano Genomics Inc last cached net income is -$26.4M (FY2025).

What are BNGO total assets?

Bionano Genomics Inc last cached total assets are $73.6M (FY2025).

What is BNGO free cash flow?

No cached cash-flow row for BNGO yet.

Not investment advice. Cached statements, not a live tape.